At a glance
- Originator Nonindustrial source
- Class Antihyperlipidaemics; Antineoplastics; Small molecules
- Mechanism of Action Sterol O-acyltransferase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Atherosclerosis; Cancer
Most Recent Events
- 30 May 2001 Profile reviewed but no significant changes made
- 08 Sep 1998 No-Development-Reported for Atherosclerosis in South Korea (Unknown route)
- 08 Sep 1998 No-Development-Reported for Cancer in South Korea (Unknown route)